Cargando…
Intraoral localized methotrexate‐associated lymphoproliferative disorders concurrent with antiresorptive agent‐related osteonecrosis of the jaw: A case report and literature review
Intraoral localized methotrexate‐associated lymphoproliferative disorders can cause antiresorptive agent‐related osteonecrosis of the jaw associated with infection due to its immunological abnormalities and ulcer formation.
Autores principales: | Minabe, Masaki, Suzuki, Taiki, Komatsu, Masumi, Hashimoto, Kazuhiko, Nomura, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752373/ https://www.ncbi.nlm.nih.gov/pubmed/33363853 http://dx.doi.org/10.1002/ccr3.3192 |
Ejemplares similares
-
Treatment of osteonecrosis of the jaw related to bisphosphonates
and other antiresorptive agents
por: Rodriguez-Lozano, Francisco-Javier, et al.
Publicado: (2016) -
Medication-Related Osteonecrosis of the Jaw in Patients Treated Concurrently with Antiresorptive and Antiangiogenic Agents: Systematic Review and Meta-Analysis
por: Srivastava, Akanksha, et al.
Publicado: (2021) -
Antiresorptive agent-related osteonecrosis of the jaw in osteoporosis patients from Asian countries
por: Taguchi, Akira, et al.
Publicado: (2017) -
Review and Update of the Risk Factors and Prevention of Antiresorptive-Related Osteonecrosis of the Jaw
por: Kim, Ha Young
Publicado: (2021) -
Incidence of antiresorptive agent-related osteonecrosis of the jaw: A multicenter retrospective epidemiological study in Hyogo Prefecture, Japan
por: Nashi, Masanori, et al.
Publicado: (2023)